Ruxience, containing the active ingredient rituximab, is used to treat specific conditions, particularly certain types of B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia.
Ruxience Uses Explained
Ruxience is a medication primarily indicated for treating specific types of blood cancers and is also being explored for other conditions. Here’s a detailed breakdown:
- Treatment of Certain B-Cell Non-Hodgkin Lymphomas: Ruxience, alone or with other drugs, is used in adults who have specific types of B-cell non-Hodgkin lymphoma that are CD20 positive.
- Treatment of Chronic Lymphocytic Leukemia (CLL): Similarly, Ruxience is used alone or in combination with other medications to treat CD20-positive chronic lymphocytic leukemia in adults.
- Investigational Uses: The reference mentions that Ruxience is also being studied in the treatment of other conditions and types of cancer, indicating potential future applications beyond its current approved uses.
In summary, Ruxience targets CD20-positive B-cells, making it effective against certain lymphomas and leukemias. It is also under investigation for treating other diseases.
